Herceptin
NDC 50242-132 · Genentech, Inc.
Generic nameTrastuzumab
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)TRASTUZUMAB
Strength150 mg/7.4mL
Pharmacologic classHER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
Marketing categoryBLA
Packages
50242-132-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01) / 15 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg Medicare Part B payment limit (ASP + 6%): $70.24
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0069-0308 — trastuzumab-qyyp, 50242-077 — Trastuzumab and hyaluronidase-oysk, 50242-245 — pertuzumab, trastuzumab, and hyaluronidase-zzxf, 50242-260 — pertuzumab, trastuzumab, and hyaluronidase-zzxf, 55513-132 — trastuzumab-anns, 55513-141 — trastuzumab-anns, 63459-303 — TRASTUZUMAB, 67457-991 — trastuzumab, 78206-147 — trastuzumab, 83257-001 — trastuzumab-dkst, 83257-003 — trastuzumab-dkst